Gameto is a biotechnology company translating the impact of ovarian aging to develop solutions to improve fertility and stop the impact of menopause on female health.

Gameto's scientific work involves reconstituting ovarian development and function in vitro, elucidating the underlying growth factor and genetic networks that drive human ovarian development and oogenesis. We aim to leverage our allogeneic human cellular derivatives of our platform to therapeutic applications for assisted fertility and menopause.

• Industry

  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • Dr. Dina Radenkovic
  • Martin Varsavsky

  LUX Partners

  • Deena Shakir

• Latest Tweets

  • Age at #menopause is linked to #lifespan. Our friend and collaborator @karagoldmanMD on the quest for biomarkers li… https://t.co/d7yETqjN0H@GametoGen - 02:26 PM Jun 23rd
  • Fascinating article on the importance of sex in research on how pregnancy conditions affect metabolic health, leadi… https://t.co/eF6p9xlaoq@GametoGen - 03:53 PM Jun 22nd
  • Incredible new insights into post-implantation embryonic development through spatial transcriptomic profiling of th… https://t.co/XBAIJItd2w@GametoGen - 08:49 PM Jun 17th